Reports
Sale
Latin America Respiratory Inhalers Market Size, Analysis: By Product Type: Dry Powdered Inhalers, Metered Dose Inhalers, Nebulizers, Others; By Technology: Manually Operated Inhaler, Digitally Operated Inhaler; By Indication: Asthma, COPD, Others; By Distribution Channel; By End Use; Regional Analysis; Supplier Landscape; 2024-2032
Latin America Respiratory Inhalers Market Size
The global respiratory inhalers market was valued at USD 33.5 billion in 2023, with Latin America holding a significant market share. The market is driven by the rising incidence of chronic respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). It is expected to grow at a CAGR of 5.4% during the forecast period of 2024-2032, with the values likely to attain USD 53.9 billion by 2032.
Latin America Respiratory Inhalers Market Outlook
- Chronic obstructive pulmonary disease (COPD) is a prevalent respiratory condition in the Latin American region, particularly in men, smokers and ex-smokers. The rising burden of respiratory diseases is expected to directly impact the market demand.
- One of the major Latin America respiratory inhalers market trends is the growing focus on the development of eco-friendly respiratory inhaler products. In April 2024, Mundipharma and Vectura announced plans to incorporate an environmentally friendly propellant into the reformulation of flutiform used in a pressurized metered-dose inhaler (pMDI) to reduce the product’s carbon footprint.
- The growing adoption of technologically advanced inhaler devices such as digital inhalers that offer additional features such as tracking medication usage and dosage are likely to boost the market share.
Latin America Respiratory Inhalers Market Analysis
Respiratory inhalers are medical devices that are designed to provide quick relief from respiratory symptoms or deliver medication to manage chronic respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). Metered-dose inhalers are the most common type of inhalers that use a propellant to spray out the medication in a short burst. There is an increasing use of technologically advanced inhaler devices such as digital inhalers that offer additional features such as tracking medication usage and dosage. The rising adoption of such innovative inhaler solutions to monitor patient compliance and adherence is expected to propel the Latin America respiratory inhalers market growth.
In Latin America, the increasing burden of respiratory diseases is directly impacting the market dynamics. Chronic obstructive pulmonary disease (COPD) is a prevalent respiratory condition in the Latin American region, particularly in men and in smokers and ex-smokers, which drives the demand for advanced respiratory inhalers. Further, in April 2023, a study reported that the healthcare costs associated with exacerbation of COPD are very high in Brazil, reaching an amount of nearly USD 14,657 per hospitalization. This indicates the need for effective respiratory care products including inhalers to prevent the worsening of COPD symptoms and ensure consistent and proper dosing of medications, which is likely to augment the Latin America respiratory inhalers market demand.
One of the major market trends is the growing focus on the development of sustainable healthcare solutions including the development of eco-friendly respiratory inhaler products. For instance, in April 2024, global healthcare company Mundipharma and specialist inhalation contract development and manufacturing organization Vectura announced plans to incorporate an environmentally friendly propellant into the reformulation of flutiform® (indicated in the regular treatment of asthma) used in a pressurized metered-dose inhaler (pMDI) with the aim of reducing the product’s carbon footprint. Such substantial investment in the advancement of respiratory inhalers with a lower environmental impact is anticipated to elevate the market value in the forecast period.
Latin America Respiratory Inhalers Market Segmentation
The report offers a detailed analysis of the market based on the following segments:
| Market Breakup | Categories |
| Product Type | Dry Powdered Inhalers (Multi-Dose Dry Powder Inhalers, Single Dose Dry Powder Inhalers), Metered Dose Inhalers (Pressured Metered Dose Inhalers, Connected Metered Dose Inhalers), Nebulizers (Compressed Air Nebulizers, Mesh Air Nebulizers, Ultrasonic Air Nebulizers), Others |
| Technology | Manually Operated Inhaler, Digitally Operated Inhaler |
| Indication | Asthma, COPD, Pulmonary Arterial Hypertension, Other Respiratory Diseases |
| Distribution Channel | Hospital Pharmacies, Retail Pharmacies & Online Pharmacies |
| End Use | Hospitals & Clinics, Homecare Settings, Respiratory Care Centers, Others |
| Countries | Brazil, Argentina, Mexico, Others |
Leading Players in the Latin America Respiratory Inhalers Market
The key features of the market report include partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- AstraZeneca Plc
- Beximco Pharmaceuticals Ltd.
- Boehringer Ingelheim International GmbH
- Cipla Ltd
- GSK Plc
- Koninklijke Philips NV
- OMRON Corp
- PARI Respiratory Equipment, Inc.
- OPKO Health, Inc
- Teva Pharmaceutical Industries Ltd
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product Type |
|
| Breakup by Technology |
|
| Breakup by Indication |
|
| Breakup by Distribution Channel |
|
| Breakup by End Use |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Latin America Respiratory Inhalers Market Overview
3.1 Latin America Respiratory Inhalers Market Historical Value (2017-2023)
3.2 Latin America Respiratory Inhalers Market Forecast Value (2024-2032)
4 Latin America Respiratory Inhalers Market Landscape*
4.1 Latin America Respiratory Inhalers Market: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Latin America Respiratory Inhalers Market: Product Landscape
4.2.1 Analysis by Product
4.2.2 Analysis by Material
4.2.3 Analysis by Type
5 Latin America Respiratory Inhalers Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter’s Five Forces Analysis
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Latin America Respiratory Inhalers Market Segmentation (2017-2032)
6.1 Latin America Respiratory Inhalers Market (2017-2032) by Product Type
6.1.1 Market Overview
6.1.2 Dry Powdered Inhalers
6.1.2.1 Multi-Dose Dry Powder Inhalers
6.1.2.2 Single Dose Dry Powder Inhalers
6.1.3 Metered Dose Inhalers
6.1.3.1 Pressured Metered Dose Inhalers
6.1.3.2 Connected Metered Dose Inhalers
6.1.4 Nebulizers
6.1.4.1 Compressed Air Nebulizers
6.1.4.2 Mesh Air Nebulizers
6.1.4.3 Ultrasonic Air Nebulizers
6.1.5 Others
6.2 Latin America Respiratory Inhalers Market (2017-2032) by Technology
6.2.1 Market Overview
6.2.2 Manually Operated Inhaler
6.2.3 Digitally Operated Inhaler
6.3 Latin America Respiratory Inhalers Market (2017-2032) by Indication
6.3.1 Market Overview
6.3.2 Asthma
6.3.3 COPD
6.3.4 Pulmonary Arterial Hypertension
6.3.5 Other Respiratory Diseases
6.4 Latin America Respiratory Inhalers Market (2017-2032) by Distribution Channel
6.4.1 Market Overview
6.4.2 Hospital Pharmacies
6.4.3 Retail Pharmacies
6.4.4 Online Pharmacies
6.5 Latin America Respiratory Inhalers Market (2017-2032) by End Use
6.5.1 Market Overview
6.5.2 Hospitals & Clinics
6.5.3 Homecare Settings
6.5.4 Respiratory Care Centers
6.5.5 Others
6.6 Latin America Respiratory Inhalers Market (2017-2032) by Countries
6.6.1 Market Overview
6.6.2 Brazil
6.6.3 Argentina
6.6.4 Mexico
6.6.5 Others
7 Brazil Respiratory Inhalers Market (2017-2032)
7.1 Brazil Respiratory Inhalers Market (2017-2032) by Product Type
7.1.1 Market Overview
7.1.2 Dry Powdered Inhalers
7.1.2.1 Multi-Dose Dry Powder Inhalers
7.1.2.2 Single Dose Dry Powder Inhalers
7.1.3 Metered Dose Inhalers
7.1.3.1 Pressured Metered Dose Inhalers
7.1.3.2 Connected Metered Dose Inhalers
7.1.4 Nebulizers
7.1.4.1 Compressed Air Nebulizers
7.1.4.2 Mesh Air Nebulizers
7.1.4.3 Ultrasonic Air Nebulizers
7.1.5 Others
7.2 Brazil Respiratory Inhalers Market (2017-2032) by Technology
7.2.1 Market Overview
7.2.2 Manually Operated Inhaler
7.2.3 Digitally Operated Inhaler
7.3 Brazil Respiratory Inhalers Market (2017-2032) by Indication
7.3.1 Market Overview
7.3.2 Asthma
7.3.3 COPD
7.3.4 Pulmonary Arterial Hypertension
7.3.5 Other Respiratory Diseases
7.4 Brazil Respiratory Inhalers Market (2017-2032) by Distribution Channel
7.4.1 Market Overview
7.4.2 Hospital Pharmacies
7.4.3 Retail Pharmacies
7.4.4 Online Pharmacies
7.5 Brazil Inhalers Market (2017-2032) by End Use
7.5.1 Market Overview
7.5.2 Hospitals & Clinics
7.5.3 Homecare Settings
7.5.4 Respiratory Care Centers
7.5.5 Others
8 Argentina Respiratory Inhalers Market (2017-2032)
8.1 Argentina Respiratory Inhalers Market (2017-2032) by Product Type
8.1.1 Market Overview
8.1.2 Dry Powdered Inhalers
8.1.2.1 Multi-Dose Dry Powder Inhalers
8.1.2.2 Single Dose Dry Powder Inhalers
8.1.3 Metered Dose Inhalers
8.1.3.1 Pressured Metered Dose Inhalers
8.1.3.2 Connected Metered Dose Inhalers
8.1.4 Nebulizers
8.1.4.1 Compressed Air Nebulizers
8.1.4.2 Mesh Air Nebulizers
8.1.4.3 Ultrasonic Air Nebulizers
8.1.5 Others
8.2 Argentina Respiratory Inhalers Market (2017-2032) by Technology
8.2.1 Market Overview
8.2.2 Manually Operated Inhaler
8.2.3 Digitally Operated Inhaler
8.3 Argentina Respiratory Inhalers Market (2017-2032) by Indication
8.3.1 Market Overview
8.3.2 Asthma
8.3.3 COPD
8.3.4 Pulmonary Arterial Hypertension
8.3.5 Other Respiratory Diseases
8.4 Argentina Respiratory Inhalers Market (2017-2032) by Distribution Channel
8.4.1 Market Overview
8.4.2 Hospital Pharmacies
8.4.3 Retail Pharmacies
8.4.4 Online Pharmacies
8.5 Argentina Respiratory Inhalers Market (2017-2032) by End Use
8.5.1 Market Overview
8.5.2 Hospitals & Clinics
8.5.3 Homecare Settings
8.5.4 Respiratory Care Centers
8.5.5 Others
9 Mexico Respiratory Inhalers Market (2017-2032)
9.1 Mexico Respiratory Inhalers Market (2017-2032) by Product Type
9.1.1 Market Overview
9.1.2 Dry Powdered Inhalers
9.1.2.1 Multi-Dose Dry Powder Inhalers
9.1.2.2 Single Dose Dry Powder Inhalers
9.1.3 Metered Dose Inhalers
9.1.3.1 Pressured Metered Dose Inhalers
9.1.3.2 Connected Metered Dose Inhalers
9.1.4 Nebulizers
9.1.4.1 Compressed Air Nebulizers
9.1.4.2 Mesh Air Nebulizers
9.1.4.3 Ultrasonic Air Nebulizers
9.1.5 Others
9.2 Mexico Respiratory Inhalers Market (2017-2032) by Technology
9.2.1 Market Overview
9.2.2 Manually Operated Inhaler
9.2.3 Digitally Operated Inhaler
9.3 Mexico Respiratory Inhalers Market (2017-2032) by Indication
9.3.1 Market Overview
9.3.2 Asthma
9.3.3 COPD
9.3.4 Pulmonary Arterial Hypertension
9.3.5 Other Respiratory Diseases
9.4 Mexico Respiratory Inhalers Market (2017-2032) by Distribution Channel
9.4.1 Market Overview
9.4.2 Hospital Pharmacies
9.4.3 Retail Pharmacies
9.4.4 Online Pharmacies
9.5 Mexico Respiratory Inhalers Market (2017-2032) by End Use
9.5.1 Market Overview
9.5.2 Hospitals & Clinics
9.5.3 Homecare Settings
9.5.4 Respiratory Care Centers
9.5.5 Others
10 Regulatory Framework
11 Partnership and Collaborations Analysis
11.1 Analysis by Partnership Instances
11.2 Analysis by Type of Partnership
11.3 Analysis by Leading Players
11.4 Analysis by Geography
12 Supplier Landscape
12.1 Market Share by Top 5 Companies
12.2 AstraZeneca Plc
12.2.1 Financial Analysis
12.2.2 Product Portfolio
12.2.3 Demographic Reach and Achievements
12.2.4 Mergers and Acquisitions
12.2.5 Certifications
12.3 Beximco Pharmaceuticals Ltd.
12.3.1 Financial Analysis
12.3.2 Product Portfolio
12.3.3 Demographic Reach and Achievements
12.3.4 Mergers and Acquisitions
12.3.5 Certifications
12.4 Boehringer Ingelheim International GmbH
12.4.1 Financial Analysis
12.4.2 Product Portfolio
12.4.3 Demographic Reach and Achievements
12.4.4 Mergers and Acquisitions
12.4.5 Certifications
12.5 Cipla Ltd
12.5.1 Financial Analysis
12.5.2 Product Portfolio
12.5.3 Demographic Reach and Achievements
12.5.4 Mergers and Acquisitions
12.5.5 Certifications
12.6 GSK Plc
12.6.1 Financial Analysis
12.6.2 Product Portfolio
12.6.3 Demographic Reach and Achievements
12.6.4 Mergers and Acquisitions
12.6.5 Certifications
12.7 Koninklijke Philips NV
12.7.1 Financial Analysis
12.7.2 Product Portfolio
12.7.3 Demographic Reach and Achievements
12.7.4 Mergers and Acquisitions
12.7.5 Certifications
12.8 OMRON Corp
12.8.1 Financial Analysis
12.8.2 Product Portfolio
12.8.3 Demographic Reach and Achievements
12.8.4 Mergers and Acquisitions
12.8.5 Certifications
12.9 PARI Respiratory Equipment, In
12.9.1 Financial Analysis
12.9.2 Product Portfolio
12.9.3 Demographic Reach and Achievements
12.9.4 Mergers and Acquisitions
12.9.5 Certifications
12.10 OPKO Health, Inc
12.10.1 Financial Analysis
12.10.2 Product Portfolio
12.10.3 Demographic Reach and Achievements
12.10.4 Mergers and Acquisitions
12.10.5 Certifications
12.11 Teva Pharmaceutical Industries Ltd
12.11.1 Financial Analysis
12.11.2 Product Portfolio
12.11.3 Demographic Reach and Achievements
12.11.4 Mergers and Acquisitions
12.11.5 Certifications
13 Latin America Respiratory Inhalers Market – Distribution Model (Additional Insight)
13.1 Overview
13.2 Potential Distributors
13.3 Key Parameters for Distribution Partner Assessment
14 Key Opinion Leaders (KOL) Insights (Additional Insight)
15 Company Competitiveness Analysis (Additional Insight)
15.1 Very Small Companies
15.2 Small Companies
15.3 Mid-Sized Companies
15.4 Large Companies
15.5 Very Large Companies
16 Payment Methods (Additional Insight)
16.1 Government Funded
16.2 Private Insurance
16.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
Key Questions Answered in the Report
The Latin America respiratory inhalers market is expected to be driven by the rising demand for the global market, which is anticipated to grow at a CAGR of 5.4% during the forecast period of 2024-2032 and is likely to reach a market value of USD 53.9 billion by 2032.
The rising incidence of chronic respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD) is fuelling the demand for the market.
One of the significant trends in the market is the rising emphasis on the development of eco-friendly respiratory inhaler products. For instance, in April 2024, Mundipharma and Vectura announced plans to incorporate an environmentally friendly propellant into the reformulation of flutiform used in a pressurized metered-dose inhaler (pMDI) to reduce the product’s carbon footprint.
Based on the product type, the market is segmented into dry powdered inhalers (multi-dose dry powder inhalers, single dose dry powder inhalers), metered dose inhalers (pressured metered dose inhalers, connected metered dose inhalers), and nebulizers (compressed air nebulizers, mesh air nebulizers, ultrasonic air nebulizers), among others.
By technology, the market is divided into manually operated inhalers and digitally operated inhalers.
By indication, the market includes asthma, COPD, and pulmonary arterial hypertension, among other respiratory diseases.
By end use, the market is segmented into hospitals and clinics, homecare settings, respiratory care centers and others.
Major distribution channels of the market include hospital pharmacies, retail pharmacies and online pharmacies.
The market segmentation by countries includes Brazil, Argentina, and Mexico, among others.
The key players in the market are AstraZeneca Plc, Beximco Pharmaceuticals Ltd., Boehringer Ingelheim International GmbH, Cipla Ltd, GSK Plc, Koninklijke Philips NV, OMRON Corp, PARI Respiratory Equipment, Inc., OPKO Health, Inc., and Teva Pharmaceutical Industries Ltd.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2639
$2399
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 4399
$3999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 5829
$5299
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 6929
$6299
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER